Literature DB >> 21515512

Meta-analysis of aldehyde dehydrogenase 2 gene polymorphism and Alzheimer's disease in East Asians.

Pan-Pan Hao1, Yu-Guo Chen, Jia-Li Wang, Xing Li Wang, Yun Zhang.   

Abstract

BACKGROUND: The association of genetic polymorphism of mitochondrial aldehyde dehydrogenase 2 (ALDH2) and Alzheimer's disease (AD) has been controversial and has been investigated only in several small-sample studies. In the present study, we performed a meta-analysis to evaluate the cross-sectional association of ALDH2 variants and AD risk in East Asian populations.
METHODS: Trials were retrieved through MEDLINE, EMBASE, J-STAGE and the China National Knowledge Internet databases (from January 1, 1994 to November 1, 2010) without any restriction on language. Data were abstracted by a standardized protocol.
RESULTS: We found four studies of 821AD patients and 1380 healthy controls that qualified for the analysis. The variant ALDH2 genotype GA/AA was not associated with increased AD risk (odds ratio (OR) = 1.35; 95% confidence interval (CI) = 0.75-2.42; p = 0.32), even after stratification for the status of apolipoprotein E epsilon 4 allele. However, in the subgroup analyses, the association was significant for men (OR = 1.72; 95% CI = 1.10-2.67; p = 0.02).
CONCLUSIONS: This study adds to the evidence that ALDH2 GA/AA genotype increases the risk of AD among East Asian men, although the effect size is moderate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515512     DOI: 10.1017/s0317167100011938

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  22 in total

1.  Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's disease.

Authors:  Miwa Komatsu; Nobuto Shibata; Tohru Ohnuma; Bolati Kuerban; Katrin Tomson; Aiko Toda; Yuko Tagata; Tomoko Nakada; Hiromi Shimazaki; Heii Arai
Journal:  J Neural Transm (Vienna)       Date:  2013-11-08       Impact factor: 3.575

2.  Association between chemokine receptor 5 (CCR5) delta32 gene variant and atherosclerosis: a meta-analysis of 13 studies.

Authors:  Zhongwen Zhang; Ju Liu; Huanjun Wang; Hongxia Wu; Xuanmei Wu; Jianjun Dong; Lin Liao
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 3.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Authors:  Che-Hong Chen; Julio Cesar Batista Ferreira; Eric R Gross; Daria Mochly-Rosen
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

4.  A nutrigenomics approach for the study of anti-aging interventions: olive oil phenols and the modulation of gene and microRNA expression profiles in mouse brain.

Authors:  Cristina Luceri; Elisabetta Bigagli; Vanessa Pitozzi; Lisa Giovannelli
Journal:  Eur J Nutr       Date:  2015-12-22       Impact factor: 5.614

5.  ALDH7A1 rs12514417 polymorphism may increase ischemic stroke risk in alcohol-exposed individuals.

Authors:  Chun-Hsiang Lin; Oswald Ndi Nfor; Chien-Chang Ho; Shu-Yi Hsu; Disline Manli Tantoh; Yi-Chia Liaw; Daria Mochly-Rosen; Che-Hong Chen; Yung-Po Liaw
Journal:  Nutr Metab (Lond)       Date:  2022-10-18       Impact factor: 4.654

6.  Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer's disease via inhibition of ACSL4-dependent ferroptosis.

Authors:  Zhi-Yun Zhu; Yan-Dong Liu; Yan Gong; Wei Jin; Elena Topchiy; Subat Turdi; Yue-Feng Gao; Bruce Culver; Shu-Yi Wang; Wei Ge; Wen-Liang Zha; Jun Ren; Zhao-Hui Pei; Xing Qin
Journal:  Acta Pharmacol Sin       Date:  2021-03-25       Impact factor: 6.150

7.  Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.

Authors:  Margaret Chia-Ying Wey; Elizabeth Fernandez; Paul Anthony Martinez; Patricia Sullivan; David S Goldstein; Randy Strong
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

8.  Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism.

Authors:  Ching-Chi Chiu; Tu-Hsueh Yeh; Szu-Chia Lai; Yah-Huei Wu-Chou; Che-Hong Chen; Daria Mochly-Rosen; Yin-Cheng Huang; Yu-Jie Chen; Chao-Lang Chen; Ya-Ming Chang; Hung-Li Wang; Chin-Song Lu
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

9.  Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications.

Authors:  Zhongwen Zhang; Xiaoyun Wu; Tian Cai; Weiyi Gao; Xiaojun Zhou; Junyu Zhao; Jinming Yao; Hongxia Shang; Jianjun Dong; Lin Liao
Journal:  Int J Environ Res Public Health       Date:  2015-07-14       Impact factor: 3.390

10.  Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease.

Authors:  Yohan D'Souza; Ahmed Elharram; Raquel Soon-Shiong; R David Andrew; Brian M Bennett
Journal:  Mol Brain       Date:  2015-04-25       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.